treatment

Vitamin B-based treatment may permanently cure vision-robbing eye disease

Tuesday, October 25, 2011 by: S. L. Baker, features writer
Tags: vitamin B, eye disease, health news

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
CDC issues flu vaccine apology: this year's vaccine doesn't work!
Tetanus vaccines found spiked with sterilization chemical to carry out race-based genocide against Africans
Biologist explains how marijuana causes tumor cells to commit suicide
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
Companies begin planting microchips under employees' skin
NJ cops bust teenagers shoveling snow without a permit
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
Russia throws down the gauntlet: energy supply to Europe cut off; petrodollar abandoned as currency war escalates
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
Chemotherapy kills cancer patients faster than no treatment at all
FDA targets Dr. Bronner's Magic Soaps for sharing health benefits of coconut oil
Why flu shots are the greatest medical fraud in history
600 strains of an aerosolized thought control vaccine already tested on humans; deployed via air, food and water
Flu vaccine kills 13 in Italy; death toll rises
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
The 21 curious questions we're never allowed to ask about vaccines
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet

Delicious
(NaturalNews) One of 2,000 people in the U.S. is diagnosed each year with keratoconus, a vision-robbing disease usually first spotted during the teenage years. The cause isn't understood, but it is known to damage the collagen fibers that form the structure of the cornea (the outer surface of the eye). It's the cornea that allows the eye to focus properly. As keratoconus worsens over time, the cornea degenerates and becomes thinner, bulges outwards and makes clear vision impossible. Standard treatments for the disease in the U.S. include specialized eyeglasses, hard contact lenses, and implanted lenses. However, none of these can permanently correct keratoconus. Severe cases often require corneal transplants, which are not only expensive but may not always "take."

But now there is a stunning development that may soon change this outlook for those suffering from this eye disease. At the 115th Annual Meeting of the American Academy of Ophthalmology currently underway in Orlando, Florida, scientist Paolo Vinciguerra, MD, just announced the results of a study showing a vitamin-based treatment that may permanently cure keratoconus in many people.

The new treatment, which has already proven effective in Europe and other parts of the world, is called collagen crosslinking and involves applying riboflavin (a B vitamin) to the cornea, which is then exposed to a specific form of ultraviolet light. The results? Collagen fibers regenerate with new bonds forming between them, increasing the strength and stiffness of the cornea.

B vitamin may be permanent cure

The treatment not only has a high success rate in restoring vision, but it also actually combats the causes of keratoconus -- the degeneration of collagen -- and reduces the odds the eye disease will ever return.

Results of Dr. Vinciguerra's clinical trial in Milan, Italy, showed the vitamin treatment improved vision in approximately 70 percent of patients. Dr. Vinciguerra's new study confirmed that adverse effects are rare and the procedure seems to be extraordinarily safe. The treatment is currently in clinical trials in the United States and is expected to receive FDA approval in 2012.

In an American Academy of Ophthalmology session entitled "Long-term Results of Corneal Crosslinking for Keratoconus", Dr. Vinciguerra described the treatment of more than 250 keratoconus patients who received the collagen crosslinking at his clinic. Sixty-eight percent of the 500 eyes treated gained significant visual acuity. What's more, these improvements remained stable at the end of a 3 year follow-up period.

"For many people with keratoconus, collagen crosslinking can provide a better and more permanent solution to their vision problems," Dr. Vinciguerra said in a media statement. "Given that no current treatment in use in the U.S. offers permanent correction, this effective option represents a significant advance for corneal medicine."

Sources for this article include:
http://www.aao.org/
http://www.nkcf.org/en/about-keratoconus.htm...
http://www.nlm.nih.gov/medlineplus/ency/arti...

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.